HomeCASI • NASDAQ
add
CASI Pharmaceuticals Inc
Previous close
$5.52
Day range
$5.43 - $5.78
Year range
$2.07 - $8.48
Market cap
74.78M USD
Avg Volume
27.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 3.98M | -59.48% |
Operating expense | 11.62M | -23.22% |
Net income | -6.96M | 31.98% |
Net profit margin | -175.04 | -67.87% |
Earnings per share | — | — |
EBITDA | -8.62M | 0.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.73M | -67.19% |
Total assets | 51.27M | -34.16% |
Total liabilities | 42.25M | 75.81% |
Total equity | 9.02M | — |
Shares outstanding | 13.52M | — |
Price to book | 8.24 | — |
Return on assets | -43.71% | — |
Return on capital | -77.63% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -6.96M | 31.98% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Headquarters
Website
Employees
176